ALL
Company Details
Linkedin ID:
alkem-laboratories-ltd
Website:
Employees number:
15,251
Number of followers:
647,457
NAICS:
3254
Industry Type:
Homepage:
alkemlabs.com
IP Addresses:
0
Company ID:
ALK_3196569
Scan Status:
In-progress
Alkem Laboratories Ltd. Company CyberSecurity Posture
alkemlabs.com
A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India’s largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries’.
Alkem Laboratories Ltd. A.I CyberSecurity Scoring
ALL Risk Score (AI oriented)Between 750 and 799
ALL
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
ALL Global Score (TPRM)XXXX
ALL
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
ALL Company CyberSecurity News & History
Past Incidents
0
Attack Types
0
No data available
ALL Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for ALL
Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)
No incidents recorded for Alkem Laboratories Ltd. in 2025.
Incidents vs All-Companies Average (This Year)
No incidents recorded for Alkem Laboratories Ltd. in 2025.
Incident Types ALL vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Alkem Laboratories Ltd. in 2025.
Incident History — ALL (X = Date, Y = Severity)
ALL cyber incidents detection timeline including parent company and subsidiaries
ALL Company Subsidiaries
A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India’s largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries’.
Loading...
ALL Similar Companies
Torrent Pharmaceuticals Ltd
Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (C
Alembic Pharmaceuticals Limited
Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrol
For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists
MACLEODS PHARMACEUTICALS LTD.
A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment.
Glenmark Pharmaceuticals
Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the pa
At Teva, we're proud to be a different kind of global pharmaceutical leader, one that operates across the full spectrum of innovation to reliably deliver medicines to patients worldwide. For over 120 years, our commitment to bettering health has never wavered. Every day, we challenge ourselves to p
Merck KGaA, Darmstadt, Germany
We are Merck KGaA, Darmstadt, Germany and its global affiliates. We are a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to e
Servier
Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its
Intas Pharmaceuticals
Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Acc
.png)
ALL CyberSecurity News
August 12, 2025 07:00 AM
Closing Bell: Sonata Software, Alkem Lab among top gainers as Nifty closes at 24,487; Sensex drops 368 points
Nifty 50 closed at 24487.40, down 97.60 points or 0.40%, Bank Nifty ended at 55043.70, falling 467.10 points or 0.84%, and Sensex settled at...
July 16, 2025 03:58 PM
Adroit Biomeds Shareholders divests 100% stake to Alkem Laboratories
EY successfully advised Adroit Biomed Limited on its 100% stake sale to Alkem Laboratories for a total consideration of INR 140 crore.
June 18, 2025 07:00 AM
Diwakar Gupta to join Alkem Labs as Independent Director
Maharashtra: Alkem Labs has announced the appointment of Diwakar Gupta as Additional Director designated as an Independent Director on the...
May 19, 2025 07:00 AM
Cyberattack compromises Enzene Biosciences’ funds
Enzene Biosciences, the biotech subsidiary of Indian multinational pharmaceutical firm Alkem Laboratories, had its U.S. operations impacted...
May 17, 2025 07:00 AM
Pharma Giant Hit by Cyber Fraud; Financial Loss Under Probe
A cybersecurity breach at a US subsidiary of Enzene Biosciences Ltd, a wholly-owned arm of Alkem Laboratories, has resulted in the fraudulent transfer of funds.
May 16, 2025 07:00 AM
Cybersecurity incident at Alkem Labs US arm, investigation underway
Alkem Labs has announced that its subsidiary Enzene Biosciences Limited has detected a cyber security incident on its US subsidiary.
May 16, 2025 07:00 AM
Alkem reports cyber security incident at Enzene’s US subsidiary
Drugmaker Alkem Laboratories has reported a cyber security incident at its subsidiary Enzene Biosciences. The incident resulted in a fraudulent transfer of...
May 16, 2025 07:00 AM
Understanding data breach risks at India Inc
Alkem Laboratories, Sun Pharma, Dr Reddy's Labs, and Angel One face data breaches, highlighting the need for cyber security awareness.
May 16, 2025 07:00 AM
Stocks in Focus: Rail Vikas Nigam, Infosys, Alkem Laboratories, and Others
The GIFT Nifty futures, which are an early indicator of the Nifty50 index, were trading higher by 104 points at 25183, indicating that the...
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
ALL CyberSecurity History Information
Official Website of Alkem Laboratories Ltd.
The official website of Alkem Laboratories Ltd. is http://www.alkemlabs.com.
Alkem Laboratories Ltd.’s AI-Generated Cybersecurity Score
According to Rankiteo, Alkem Laboratories Ltd.’s AI-generated cybersecurity score is 776, reflecting their Fair security posture.
How many security badges does Alkem Laboratories Ltd.’ have ?
According to Rankiteo, Alkem Laboratories Ltd. currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Does Alkem Laboratories Ltd. have SOC 2 Type 1 certification ?
According to Rankiteo, Alkem Laboratories Ltd. is not certified under SOC 2 Type 1.
Does Alkem Laboratories Ltd. have SOC 2 Type 2 certification ?
According to Rankiteo, Alkem Laboratories Ltd. does not hold a SOC 2 Type 2 certification.
Does Alkem Laboratories Ltd. comply with GDPR ?
According to Rankiteo, Alkem Laboratories Ltd. is not listed as GDPR compliant.
Does Alkem Laboratories Ltd. have PCI DSS certification ?
According to Rankiteo, Alkem Laboratories Ltd. does not currently maintain PCI DSS compliance.
Does Alkem Laboratories Ltd. comply with HIPAA ?
According to Rankiteo, Alkem Laboratories Ltd. is not compliant with HIPAA regulations.
Does Alkem Laboratories Ltd. have ISO 27001 certification ?
According to Rankiteo,Alkem Laboratories Ltd. is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of Alkem Laboratories Ltd.
Alkem Laboratories Ltd. operates primarily in the Pharmaceutical Manufacturing industry.
Number of Employees at Alkem Laboratories Ltd.
Alkem Laboratories Ltd. employs approximately 15,251 people worldwide.
Subsidiaries Owned by Alkem Laboratories Ltd.
Alkem Laboratories Ltd. presently has no subsidiaries across any sectors.
Alkem Laboratories Ltd.’s LinkedIn Followers
Alkem Laboratories Ltd.’s official LinkedIn profile has approximately 647,457 followers.
NAICS Classification of Alkem Laboratories Ltd.
Alkem Laboratories Ltd. is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
Alkem Laboratories Ltd.’s Presence on Crunchbase
No, Alkem Laboratories Ltd. does not have a profile on Crunchbase.
Alkem Laboratories Ltd.’s Presence on LinkedIn
Yes, Alkem Laboratories Ltd. maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/alkem-laboratories-ltd.
Cybersecurity Incidents Involving Alkem Laboratories Ltd.
As of December 11, 2025, Rankiteo reports that Alkem Laboratories Ltd. has not experienced any cybersecurity incidents.
Number of Peer and Competitor Companies
Alkem Laboratories Ltd. has an estimated 5,413 peer or competitor companies worldwide.
Alkem Laboratories Ltd. CyberSecurity History Information
How many cyber incidents has Alkem Laboratories Ltd. faced ?
Total Incidents: According to Rankiteo, Alkem Laboratories Ltd. has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at Alkem Laboratories Ltd. ?
Incident Types: The types of cybersecurity incidents that have occurred include .
Incident Details
What are the most common types of attacks the company has faced ?
Additional Questions
.png)
Latest Global CVEs (Not Company-Specific)
Description
FreePBX Endpoint Manager is a module for managing telephony endpoints in FreePBX systems. Versions prior to 16.0.96 and 17.0.1 through 17.0.9 have a weak default password. By default, this is a 6 digit numeric value which can be brute forced. (This is the app_password parameter). Depending on local configuration, this password could be the extension, voicemail, user manager, DPMA or EPM phone admin password. This issue is fixed in versions 16.0.96 and 17.0.10.
Risk Information
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
Neuron is a PHP framework for creating and orchestrating AI Agents. In versions 2.8.11 and below, the MySQLWriteTool executes arbitrary SQL provided by the caller using PDO::prepare() + execute() without semantic restrictions. This is consistent with the name (“write tool”), but in an LLM/agent context it becomes a high-risk capability: prompt injection or indirect prompt manipulation can cause execution of destructive queries such as DROP TABLE, TRUNCATE, DELETE, ALTER, or privilege-related statements (subject to DB permissions). Deployments that expose an agent with MySQLWriteTool enabled to untrusted input and/or run the tool with a DB user that has broad privileges are impacted. This issue is fixed in version 2.8.12.
Risk Information
cvss3
Base: 9.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
Description
Neuron is a PHP framework for creating and orchestrating AI Agents. Versions 2.8.11 and below use MySQLSelectTool, which is vulnerable to Read-Only Bypass. MySQLSelectTool is intended to be a read-only SQL tool (e.g., for LLM agent querying, however, validation based on the first keyword (e.g., SELECT) and a forbidden-keyword list does not block file-writing constructs such as INTO OUTFILE / INTO DUMPFILE. As a result, an attacker who can influence the tool input (e.g., via prompt injection through a public agent endpoint) may write arbitrary files to the DB server if the MySQL/MariaDB account has the FILE privilege and server configuration permits writes to a useful location (e.g., a web-accessible directory). This issue is fixed in version 2.8.12.
Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:N
Description
Okta Java Management SDK facilitates interactions with the Okta management API. In versions 11.0.0 through 20.0.0, race conditions may arise from concurrent requests using the ApiClient class. This could cause a status code or response header from one request’s response to influence another request’s response. This issue is fixed in version 20.0.1.
Risk Information
cvss3
Base: 8.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:L
Description
The Auth0 Next.js SDK is a library for implementing user authentication in Next.js applications. When using versions 4.11.0 through 4.11.2 and 4.12.0, simultaneous requests on the same client may result in improper lookups in the TokenRequestCache for the request results. This issue is fixed in versions 4.11.2 and 4.12.1.
Risk Information
cvss3
Base: 5.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:U/C:H/I:L/A:N
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=alkem-laboratories-ltd' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
